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Abstract
There are about 100 single point mutations of copper, zinc superoxide dismutase 1 (SOD1) which are reported (http://alsod.iop.
kcl.ac.uk/Als/index.aspx) to be related to the familial form (fALS) of amyotrophic lateral sclerosis (ALS). These mutations are
spread all over the protein. It is well documented that fALS produces protein aggregates in the motor neurons of fALS patients,
which have been found to be associated to mitochondria. We selected eleven SOD1 mutants, most of them reported as
pathological, and characterized them investigating their propensity to aggregation using different techniques, from circular
dichroism spectra to ThT-binding fluorescence, size-exclusion chromatography and light scattering spectroscopy. We show
here that these eleven SOD1 mutants, only when they are in the metal-free form, undergo the same general mechanism of
oligomerization as found for theWTmetal-free protein. The rates of oligomerization are different but eventually they give rise to
the same type of soluble oligomeric species. These oligomers are formed through oxidation of the two free cysteines of SOD1 (6
and 111) and stabilized by hydrogen bonds, between beta strands, thus forming amyloid-like structures. SOD1 enters the
mitochondria as demetallated and mitochondria are loci where oxidative stress may easily occur. The soluble oligomeric
species, formed by the apo form of both WT SOD1 and its mutants through an oxidative process, might represent the precursor
toxic species, whose existence would also suggest a common mechanism for ALS and fALS. The mechanism here proposed for
SOD1 mutant oligomerization is absolutely general and it provides a common unique picture for the behaviors of the many
SOD1 mutants, of different nature and distributed all over the protein.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a neurological disease that
causes the death of motor neurons with consequent muscular
paralysis [1]. Although it is predominantly a sporadic disease, 10%
of the ALS cases are described as familial (fALS). A link between
fALS and mutations in the SOD1 gene was first suggested in 1993
[2], and over 100 fALS-linked mutations, distributed throughout
the SOD1 gene, are now associated with approximately 20% of
the fALS cases [1,3,4]. The pathogenicity of SOD1 mutants has
been demonstrated to be due to the gain of a toxic function and
not to the loss of the normal function. Thus SOD1 knock-out mice
do not show any ALS symptoms, whereas transgenic mice,
expressing, for example, the fALS associated mutant G93A human
SOD1, develop the symptoms, despite expression of endogenous
mouse SOD1 [1,5]. Studies of the properties of the isolated ALS-
mutant SOD1 proteins have not revealed the nature of their toxic
properties. Some of the mutations differently affect protein
stabilities, metal ion affinities and SOD1 activities, while others
do not [3,6,7,8]. Thus the molecular mechanisms by which the
mutations cause fALS are currently unknown.
Protein aggregates and inclusions are a common pathological
feature of many neurological disorders such as Huntington’s,
Alzheimer’s and Parkinson’s diseases [9]. In these neurodegenerative
diseases, misfolding, aggregation, and precipitation of proteins seem
to be directly related to neurotoxicity. The finding of proteinaceous
aggregates containing SOD1 in motor neurons of postmortem fALS
patients and transgenic mice was therefore a major advance in the
field since it suggested that aggregation of SOD1 is related to the
pathology of SOD1-linked fALS [10]. As in the other neurodegen-
erative diseases, it appears unlikely that the visible SOD1-containing
inclusions themselves are toxic; rather their presence suggests that
smaller, soluble high molecular weight oligomeric precursor species
containing SOD1 are being generated in vivo [11].
Eukaryotic copper, zinc superoxide dismutase (SOD1) is a 32-
kDa homodimeric metalloenzyme, found predominantly in the
cytosol, but also in the mitochondrial intermembrane space,
nucleus, and peroxisomes. Each of the two subunits of SOD1
forms an eight-stranded Greek key b-barrel and contains an active
site that binds a catalytic copper ion (binding residues: His46,
His48, His63 and His120) and a structural zinc ion (binding
residues: His63, His71, His80 and Asp83). Its functional role is
that of catalyzing the dismutation of superoxide radical to
dioxygen and hydrogen peroxide [12,13]. The mature, correctly
folded and enzymatically active form of SOD1 is obtained in vivo
through several post-translational modifications: acquisition of
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zinc and copper ions, disulfide bond formation, and dimerization
[3,14,15]. Attention has been focused on how mutations could
affect these steps of SOD1 maturation. We have recently shown that
wild type (WT) human SOD1, when lacking both its metal ions,
forms large, stable, soluble, amyloid-like protein oligomers in
solutions exposed to air, under physiological conditions (37uC, pH
7, and 100 mM protein concentration) [16]. Oligomerization was
shown to occur through a combination of oxidation of Cys 6 and Cys
111 and formation of amyloid-like interactions between beta strands,
as judged by the ability of the oligomers to bind the amyloid-binding
dye thioflavin T (ThT), a benzothiazole dye that exhibits increases in
fluorescence intensity upon binding to amyloid fibers [17].
The next question therefore was to discover whether fALS-
linked mutations in SOD1 oligomerize through the same,
common mechanism and, if so, whether this mechanism can be
proposed as generally associated to the ALS pathology.
With this aim, we selected a number of mutants, most of which
related to fALS. All of them were characterized in the apo and
zinc-reconstituted states with respect to their ability to form soluble
large molecular weight oligomers. Just as in the WT SOD1, we
found that demetallation is the key factor for fALS-mutant SOD1
oligomerization and that intersubunit disulfide bonds involving the
free Cys residues, Cys6 and Cys111, as well as formation of ThT-
binding non-covalent interactions, uniquely characterize the
soluble oligomeric species formed. This sheds a new light on the
entire story of ALS and its familial cases. It may be suggested that
metal-free SOD1 itself is a cause of ALS and that a number of
mutants associated with fALS may be more prone to oligomer-
ization in vivo. We found that all of the fALS mutant SOD1
proteins tested, just like WT SOD1, form these high molecular
weight oligomers, and that some, but not all, of the fALS mutant
SOD1 proteins form them at remarkably fast rates.
Results
We have recently reported that apo WT SOD1 gives rise to
soluble oligomers under aerobic conditions when the protein is
kept at 37uC and at a concentration and pH close to physiological,
i.e., 100 mM and pH 7. The resulting soluble oligomers are formed
by intermolecular disulfide covalent bonds and by non-covalent
interactions between beta strands, forming amyloid-like structures
capable of binding ThT [16].
The SOD1 mutants (figure 1), which are reported to be linked
to fALS disease, were selected following the criteria indicated in
Table 1. We selected mutants spread over the entire protein: some
of the mutations are located at the subunit-subunit interface, some
add a positively charged residue, others substitute an hydrophobic
residue with an hydrophilic one, or some produce a simple side
chain size variation. Other mutations are on residues either
located on secondary structural elements, namely b strands, or just
outside them, with change to residues favoring a helical
conformation. We also selected a mutation, on a residue in a
loop, which introduces a negative charge in the hydrophobic core
of the protein. Finally, we introduced two mutations not reported
to be related to fALS. Each of these mutant proteins was analyzed
with respect to its behavior toward oligomerization, and
correlations were sought between the mutant behavior, the nature
of the mutation, and its location on the sequence. We purposely
introduced the mutations on the ‘‘real’’ WT SOD1 and not on the
thermostable form where the two free cysteines (6 and 111) are
changed to alanine and serine, respectively (so-called AS SOD1)
[18]. This is an essential condition as we have shown that the
presence of these two cysteines is the key for SOD1 oligomeri-
zation [16].
Each of the mutants, in the zinc-reconstituted as well as in the apo
form, retained the dimeric quaternary structure, as assessed by gel
filtration chromatography, which also demonstrated the absence of
any significant amount of high molecular weight species. Circular
dichroism (CD) spectra on both metallated and apo proteins
indicated that the secondary structure present in WT SOD1 was
fully conserved in all of the mutants. It has been shown previously
that reduction of the intramolecular disulfide bond of apo WT
SOD1 causes complete monomerization [15]. We therefore
inferred, from the dimeric state of the apo form of all the mutant
proteins, that the intrasubunit disulfide bond was intact. For some of
the mutants (T54R, V97M and I113T), the folded state of the
proteins and the intact disulfide bond were also experimentally
confirmed from their 1H-15N HSQC NMR spectra since their
cysteine residues 57 and 146 have shifts very close to those observed
for oxidized WT SOD1, but far from those of reduced WT.
Optical and fluorescence spectroscopies, the latter with the use
of the ThT, coupled with gel chromatography, showed that the
zinc-bound proteins did not give rise to any oligomeric species
Figure 1. SOD1 investigated mutations. Location of the investi-
gated mutations (red spheres) mapped on the (Cu,Zn) WT SOD1
structure (pdb-ID 1l3n).
doi:10.1371/journal.pone.0001677.g001
Table 1. Mutants studied in this work and their criteria of
selection
Mutations Criteria of choice
Thr54Arg Dimer interface, charge change to positive amino acid
Val87Met Amino acid with a propensity within b strand
Asp90Ala Amino acid at the protein surface
Gly93Ala Amino acid with a propensity just outside b strand
Gly93Asp Charge variation (to negative residue) on buried amino acid
Val97Met Amino acid with a propensity within b strand
Ile113Phe Dimer interface, still hydrophobic amino acid
Ile113Thr Dimer interface, change to hydrophilic amino acid
Leu144Phe Amino acid with decreased a propensity just outside b strand
Ile35Thr Non-ALS mutation located on the only SOD1 b strand without
mutations; mutation from polar hydrophobic amino acid to
non-polar hydrophilic amino acid
Leu67Val Non-ALS mutation on a pathogenic site located on the zinc-
binding loop
doi:10.1371/journal.pone.0001677.t001
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when they are incubated at pH 7, 37uC, 100 mM concentration,
for periods of time longer than a month. The absence of formation
of any large molecular weight species was confirmed by gel
filtration chromatography. Consistently, turbidity at 400 nm
showed no insoluble precipitate. These data indicate that, similar
to WT SOD1 [16], the zinc-bound forms of any SOD1 mutant are
stable even under prolonged incubation at 37uC.
By contrast, the behavior of the metal-free (apo) form was
dramatically different. Upon incubation at 37uC in the air, a
progressive increase in ThT-binding fluorescence was observed for
the apo form of all the mutants. Figure 2 shows the ThT-binding
behavior of the eleven SOD1 mutants, together with that of apo
WT SOD1, over a period of more than one year. The temperature
dependence of this process was tested for incubations ranging from
15 to 40uC. While at 15uC the oligomerization process is much
slower starting after 5–6 days, in the range 36–40uC a difference of
one degree Celsius almost doubles the detected rates (data not
shown). When a reducing agent such as DTT was added to the
solutions of the mutants (tested for T54R, V87M, D90A, G93A,
V97M, I113T and L144F), the oligomeric species were destroyed,
leading to monomeric species, thus showing that the oligomeriza-
tion occurs through disulphide bonds. The soluble oligomers,
which appear to have a similar amyloid-like structure, as judged by
their ThT-binding behavior, are stabilized by H-bond interactions
between beta strands of SOD1 subunits. To test further for the
existence of these non-covalent interactions, GdnHCl, a cauthropic
agent that breaks hydrogen bonds, was added to the oligomers. For
each of the mutants tested (T54R, V87M, D90A, I113F, I113T
and L144F), the ThT-binding fluorescence was quenched in few
minutes, whereas gel filtration of the resulting solutions showed that
high-molecular-weight species remained present. While the loss of
ThT-binding ability is due to the disruption of the amyloid-like
structure of the oligomeric assemblies, the persistence of the
oligomeric state is due to the covalent disulfide bonds between the
free cysteines of the monomeric subunits.
The rates of oligomerization and consequently of fluorescence
increase, is found to depend on the nature of the mutation, being for
some mutants strikingly different from that of apoWT SOD1. In
particular, three mutants (G93A, V97M and I113T) showed a very
fast initial rate of oligomerization, more than twice that of WT
SOD1. I35T, a mutant not currently linked to fALS, showed a
significantly slower rate of oligomer formation than these three, but
the rate was still higher relative to the WT SOD1 protein. The other
mutants showed rates of oligomer formation very similar to apo WT
SOD1 or, in one case, i.e., T54R SOD1, slightly lower than it. Thus
the rates of aggregation for the fALS mutant proteins studied can be
divided in two groups, some with rates of oligomerization very similar
to that of apo WT SOD1 and three others much faster, with one,
non-ALS mutant SOD1 oligomerizing at an intermediate rate. It is
important to stress that in no case did a human SOD1 apoprotein fail
to form soluble, high molecular weight oligomers. Repeated trials of
each of the mutants also established that the kinetics of oligomer
formation were highly reproducible as monitored by increases in
ThT fluorescence. The data for T54R, D90A, I113T SOD1, and
WT SOD1 apoproteins are shown in figure S1.
It is not only the location of the mutation, but also the nature of
the amino acid substitution that determines the oligomerization
rate. For example, mutation of Ile113 induces a very fast rate of
oligomerization, much faster than WT, when is substituted with
Thr, but close to that of WT when Ile is replaced by Phe.
Similar oligomerization behavior is also observed for the two
mutants, up to now not reported to be involved in ALS. The I35T
mutant, located in b3 strand, showed a fast increase in ThT
fluorescence (figure 2), and therefore in the rate of oligomerization,
as also evidenced by the gel chromatographic analysis (data not
shown), while the other mutant here investigated, L67V,
ologomerizes with a slower rate, similarly to WT SOD1. The
oligomerization of mutants I35T and L67V, in their apo forms,
supports our mechanism suggesting that the process would take
place for any mutation only when the protein is in the apo form,
but not in the zinc-bound form, as we have extensively verified.
In any case, it is important to note that, despite the different
aggregation rates, the fluorescence limits at very long times (about
1 year) are similar, indicating the formation of very large
molecular weight oligomers for WT and all of the mutant
SOD1 proteins studied (figure 2 and figure S1).
The pattern of oligomerization, detected through fluorescence,
was paralleled by gel filtration data. The data for the two mutants
with the two extreme oligomerization rates, as observed in the
fluorescence experiments, (I113T and T54R) are shown in figures 3
and 4. After about 100 hours, while I113T was mostly in high
molecular weight states, even if not yet as the final, highest molecular
weight ones, mutant T54Rwas still essentially all in the dimeric state.
Gel filtration data also indicated that the final status (after about one
year) contains a distribution of high MW species, up to the column
cut off (76106 Da). The presence of intermediate MW species is also
observed during the long period of the aggregation process; they
eventually evolve towards the final very high MW species. Multi-
angle light scattering analyses of the samples along the oligomeri-
zation process also showed that the average molecular weight was
increasing as a function of time (figure 3, Table S1), with a decrease
of the fraction of the dimeric species and the increase of that of the
oligomers. The increase in ThT-fluorescence and that in molecular
weight from light scattering go in parallel, with a linear correlation
between the fraction of aggregated specie (non-dimer) and the ThT-
binding fluorescence at each period of incubation (figure 5). This
correlation indicates that similar increase in fluorescence corre-
sponds to similar increase in oligomeric species. Multi-angle light
scattering data of samples after long periods of incubation, when they
reach a steady state condition, provide very similar average
molecular weights for all the mutants (of the order of 106 Da),
indicating that the oligomers eventually have essentially the same
size, independently of the rate of aggregation.
Figure 2. Formation of ThT-binding structures when apo SOD1
mutants and WT are incubated at 37uC. Fluorescence due to ThT
binding to SOD1 mutants (presented as arbitrary units, A.U.) for apo
T54R SOD1 (N); apo L67V SOD1 (D), apo D90A SOD1 (=), apo I113F SOD1
(%), apo V87M SOD1 (.), apo WT SOD1 (O), apo L144F SOD1 (&), apo
I35T SOD1 (m), apo V97M SOD1 (m), apo G93A SOD1 (e), apo I113T
SOD1 (¤), during the incubation of the samples at 37uC. Apo G93D
SOD1 mutant is not reported because the oligomeric species formed
precipitates after about 30 hours of incubation.
doi:10.1371/journal.pone.0001677.g002
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Discussion
It is now well assessed that, in neuronal tissues of SOD1-linked
fALS patients, visible protein aggregates are present that contain
aggregated SOD1 and that these aggregates are essentially
associated to mitochondria [19,20]. What is still not understood
are the factors and the mechanisms inducing this aggregation.
fALS-related SOD1 mutations have been found distributed all
over the entire protein and of every possible nature (i.e. charge
reversal, charge increase or decrease, from hydrophobic to
hydrophilic, different residue size, etc.) with no reasonable
correlation/rational between the mutation and the ability to give
rise to aggregates. It was already suggested that metal-deficient
forms of SOD1 mutants might have a role in fALS [21,22] but no
general relation has been suggested up to now between lack of
metal ion and protein aggregation.
Our data on WT SOD1 and on its mutants would then suggest
a general feature in the relation between SOD1 and ALS: the apo
protein, before it is metalated, is susceptible to oligomerization.
Lack of oligomer formation for the metallated proteins shows that
metallation is a key factor to inhibit oligomerization. SOD1 or its
mutants enter mitochondria as demetallated [23,15] and, as such,
may undergo an abundant oxidation and consequently oligomer-
ization on the way to maturity i.e. before metal binding.
Therefore, independent of the presence and of the nature of the
mutation, factors that prevent SOD1 from being efficiently and
quickly metalated could lead to protein oligomerization and
consequently to disease onset. While it has been shown that the
metal-loaded forms of most of the mutant SOD1’s are stable and
hardly lose the metal ions once metalated as also holds for WT
SOD1 [24], several ALS mutations have instead the largest effect
on the most immature forms of SOD1; some mutations destabilize
the metal-free and disulfide-reduced polypeptide to the point that
these forms are unfolded at physiological temperatures [7,25].
Not all fALS-related mutants enhance the oligomerization
process. Actually most of them behave quite similarly to apo WT
(figure 2). Only three mutants, out of the eleven investigated, show
a significant increase in the initial oligomerization rates compared
to the WT protein. We therefore suggest that the presence of a
mutation and its location and type would only modulate the rate of
Figure 3. Formation of oligomeric structures when apo I113T SOD1 mutant is incubated at 37uC. (A) Fluorescence due to ThT binding to
SOD1 mutants (presented as arbitrary units, A.U.) for apo I113T SOD1 during the incubation of the samples at 37uC. Panels (B) and ( C ) shows the size
exclusion chromatograms on a G2000SWXL and a G4000SWXL Tosoh columns respectively, corresponding to the samples analyzed by light scattering. The
void volume is labeled V0. (D) Variation in species distribution during incubation of apo I113T SOD1. Each curve shows the molecular weight distribution
detected by light scattering for the sample after different incubation times at 37uC. In all four panels the samples can be identified according to the
following colors: before incubation (—), after 16 hours (—), 40 hours (—), 62 hours (—), 4 days (—) and 6 months (—) of incubation at 37uC.
doi:10.1371/journal.pone.0001677.g003
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the aggregation process. This modulation could occur in two ways:
1) the mutation could influence the local structural and dynamical
properties of the apo state, exposing areas of the protein that make
it prone to oligomerization through disulfide bond formation
between the free cysteines of different SOD1 molecules [16]. The
lack of metal ions leads, indeed, to a more disordered SOD1
structure, thus making the free cysteines more exposed, solvent
accessible, and less structurally constrained than in the metallated
form, as observed in the solution structure of the apo form of a
stable monomeric species, characterized by a dramatic increase in
protein flexibility, with regions experiencing random coil structural
features. This acquired freedom could be affected differently by
the various mutations. 2) the mutations could modulate the rate of
metalation. If the protein remained for an abnormally long period
of time in the apo state, our results suggest that the SOD1
apoprotein, WT or mutant, would be more prone to aggregation.
The aggregation process we observe is strongly sensitive to
temperature and obviously to the redox conditions of the
environment. Because of the involvement of disulfide bond
formation, an oxidative stress would be expected to favor the
process, while a reducing environment would prevent aggregation.
Indeed, it has been suggested that the redox state of the cell may
play a role in the aggregation process [26]. SOD1 is mainly
present in two different cell compartments, i.e. cytoplasm and
mitochondria, where it independently acquires metal ions. These
two cell compartments have quite different redox properties,
which could further modulate the aggregation process in vivo. It has
been proposed that an important toxic property of most
mutSOD1s derives from their high level of accumulation in
mitochondria in an aggregated state with cross-linked mutSOD1s
and that this localization is caused by the aberrant reactivity of
cysteines driven by the more oxidizing redox environment of these
mitochondria [26]. Recent studies suggest that a non-physiological
intermolecular disulfide bond between cysteines at positions 6 and
111 of mutant SOD1 is important for high molecular weight
aggregate formation in cells [27].
Our results show that WT, as well as all the SOD1 mutants here
studied, form similar high molecular weight oligomers when these
proteins, in the apo dimeric form with the intramolecular disulfide
bonds intact, are kept in conditions very close to the physiological
ones (figure 6). The finding that WT and all the mutants,
independently of the nature and location of the mutation, undergo
the same type of oligometization suggest a general, unifying
picture of SOD1 aggregation that could operate when either wild
type or mutant SOD1 proteins are in the metal-free state.
Although we cannot exclude other mechanisms in SOD1-linked
familial ALS, the one proposed here has the strength of explaining
how a large and diverse set of SOD1 mutant proteins all could
lead to disease through the same mechanism.
Despite our efforts to build up a correlation between our results
and the severity of the disease, the data on the latter are few. The
number of cases documented, in particular for the mutations
reported by us, is not exhaustive and broad enough to build up a
relationship. Still our approach has the potentiality to establish
such correlation as soon as enough data become available.
Figure 4. Formation of oligomeric structures when apo T54R
SOD1 mutant is incubated at 37uC. (A) Fluorescence due to ThT
binding to SOD1 mutants (presented as arbitrary units, A.U.) for apo
T54R SOD1 during the incubation of the samples at 37uC. Panels (B)
and ( C ) shows the size exclusion chromatograms on a G2000SWXL and
a G4000SWXL Tosoh columns respectively, corresponding to the
samples analyzed by light scattering. The void volume is labeled V0.
In all four panels the samples can be identified according to the
following colors: before incubation (—), after 66 hours (—), 4.8 days (—
), 6.8 days (—),7.5 days (—), and 13 months (—) of incubation at 37uC.
In panel (B) the zinc reconstituted sample (—) is also reported.
doi:10.1371/journal.pone.0001677.g004
Figure 5. Correlation between percentage of aggregated
species and ThT-binding fluorescence. Percentage of aggregated
species (non-dimer), determined by light scattering measurements, vs
ThT-binding fluorescence for apo WT SOD1 (O) and apo I113T SOD1 (¤)
during the incubation of the samples at 37uC. Error bars are derived
from the molecular mass errors of the light scattering experiments.
doi:10.1371/journal.pone.0001677.g005
SOD1 Mutants and Oligomers
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Materials and Methods
Sample Preparation—WT SOD1 and its mutants were expressed
in the Escherichia coli BL21(DE3) strain. Mutations were performed
using a QuikChangeTM site-directed mutagenesis kit (Stratagene).
The proteins, obtained from cells grown in LB medium, were
isolated by osmotic shock in a 20 mM Tris, 5 mM dithiothreitol
(DTT) buffer at pH 8. After incubation for 30 minutes at 37uC,
the proteins were centrifuged at 40000 rpm for 20 minutes.
Supernatants were purified following a reported procedure [28]
modified by the addition of 1 mM DTT to each chromatographic
buffer. The proteins obtained with this procedure contained
substoichiometric amounts of the metal ions (Table S2). The metal
ions were completely removed, at 25uC, to prepare the
demetallated (apo) form, according to previously published
protocols [29], and the zinc reconstituted forms were prepared,
as well, as previously described [15]. Metal content of the various
forms of SOD1 was checked by inductively coupled plasma mass
spectrometry (ICP-MS) using a Thermo Jarrell Ash Atomscan
Model 25 Sequential inductively coupled spectrometer (Table S2).
The dimeric state of the apo form of the mutants at time zero of
the incubation was checked through gel filtration chromatography.
Spectroscopic characterization—Protein samples were 100 mM in
SOD1 concentration (as dimer) in 20 mM phosphate buffer at pH
7. The proteins were incubated at 37uC to mimic physiological
conditions. Optical and fluorescence spectroscopies, coupled with
gel filtration chromatography, were used to monitor the formation
of oligomeric species at these sample conditions. The analysis were
carried out in both the zinc-bound and apo forms of the proteins.
Far-UV CD spectra (190–250 nm) of SOD1 were recorded on
JASCO J-810 spectropolarimeter. A cell with a path length of
1 mm was used for the measurement, and the parameters were set
as follows: bandwidth, 2 nm; step resolution, 1 nm; scan speed,
20 nm/min; and response time, 2 s. Each spectrum was obtained
as the average of four scans. The protein concentration was
typically around 8–10 mM. Prior to the calculation of the mean
residue molar ellipticity, all of the spectra were corrected by
subtracting the contributions from the buffer. Spectra were then
smoothed using adjacent averaging or Fast Fourier transform
filter. Quantitative estimations of the secondary structure contents
were made using the DICROPROT software package [30].
Fluorescence was followed with Thioflavin T, (ThT) probe, which
specifically binds to amyloid-like structures [17]. Free ThT has
excitation and emission maxima at 350 nm and 450 nm, respec-
tively. However, upon binding to amyloid-like oligomers, the
excitation and emission maxima change to 450 and 485 nm,
respectively. 54 ml aliquots of sample were added to 646 ml of a
215 mM ThT solution in a 20 mM phosphate buffer at pH 7. The
solution fluorescence emission was measured, over time of
incubation,with a Cary 50 Eclipse Spectrophotometer supplied with
a Single cell Peltier thermostatted cell holder regulated at 37uC. The
background fluorescence spectrum of the buffer was subtracted. The
excitation wavelength was 446 nm (bandwidth 10 nm) and the
emission was recorded at 480 nm (bandwidth 10 nm). Fluorescence
intensity at 483 nm was plotted against time of incubation.
Turbidity was measured at 400 nm to detect possible formation
of insoluble precipitate. Solution turbidity was measured as
apparent absorbance at 400 nm using a Cary UV-visible
spectrophotometer. Experiments were performed by diluting
120 ml of the incubation SOD1 stock solution into 280 ml of
20 mM phosphate buffer at pH 7. A 1 cm quartz cuvette was
used. Instrumental detection limit was 0.001 at 400 nm.
NMR data were acquired at 288 and 298 K on a 700 or a 900
Bruker spectrometer operating at proton nominal frequencies of
700.13 and 900.13 MHz, respectively. A triple resonance Cryo-
probe equipped with pulsed field gradients along the z-axis was used.
The two-dimensional 1H-15N HSQC spectra, performed to monitor
Figure 6. Mutants SOD1 aggregation. Formation of soluble oligomers occuring when apo WT SOD1 protein is kept close to physiological
conditions for an extended period of time. In the absence of metal ions, SOD1 proteins form abnormal disulfide cross-links though the two free
cysteines (Cys 6 and Cys 111) and noncovalent associations with other SOD1 monomers or dimers.
doi:10.1371/journal.pone.0001677.g006
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the folding of the protein mutants, were collected on 100 mM
samples of 15N-labeled E,E- and E,Zn-hSOD1SS mutant proteins in
20 mM sodium phosphate buffer (pH 7).
Monitoring SOD1 Aggregation by Gel Filtration and Light Scattering—
100 ml aliquots of the incubated proteins at 37uC were periodically
taken and analyzed by gel filtration on Superdex 75 HR 10/30
(Amersham Biosciences) at room temperature. The column was
preequilibrated with 20 mM potassium phosphate, pH 7.0, and
the flow rate was 0.6 ml/min. The chromatogram, which
monitors the species formed during incubation, was obtained by
monitoring the absorbance at 280 nm. 20 ml aliquots of the
incubated proteins at 37uC were also periodically taken and
analyzed by gel filtration on G2000SWXL and G4000SWXL
(Tosoh Bioscience) columns at room temperature. The columns
were preequilibrated with 20 mM potassium phosphate, pH 7.0,
and the flow rates were 0.7 and 1 ml/min respectively. The
chromatogram, which monitors the species formed during
incubation, was obtained by monitoring the absorbance at
280 nm. A species, present in small amount, was observed in the
chromatographic spectra of mutants I113T and T54R, eluting
after about 12.0 ml. This species might be due to a fragment from
some degradation, which takes place during the aggregation
process. We can exclude that it is due to a monomeric species
either folded or unfolded as they elute only slightly later than the
dimeric species (folded) or even earlier than it (unfolded) (data not
shown). Further studies are underway to elucidate this issue.
While Superdex 75 HR 10/30 is a semi-preparative gel filtration
columns, the G2000/4000SWXL are analytical ones. Their void
volumes are 75 kDa, 150 kDa and 7,000 kDa respectively. The
Superdex column was used when a separation of the dimer from the
rest of the oligomeric species was necessary for further analysis. The
G2000SWXL analytical column was used to monitor the very initial
steps of the oligomerization process while the successive time points,
in which a larger oligomer, with MW higher than 150 kDa, was
formed, were better observed with the G4000SWXL column.
The G2000SWXL and G4000SWXL columns were also
connected to a light scattering spectrometer. The online multi-
angle light scattering (MALS) detector (DAWN EOS, Wyatt
Technology, Santa Barbara, CA) and differential refractive index
(DRI) detector (Optilab DRI, Wyatt Technology) setup was used
to measure the light scattered as a function of angle and absolute
protein concentration of fractions eluting from the size-exclusion
chromatography column. The Zimm/Debye approximations were
used in the Astra software (Wyatt Technology) to estimate molar
mass. Data were fit using a second-order polynomial. The analysis
was performed for each one of the 20 ml aliquots periodically taken
from the incubation batches so as to monitor the increase in
molecular weight of the soluble species formed during aggregation.
Supporting Information
Figure S1 Formation of ThT-binding structures when apo
SOD1 mutants and WT are incubated at 37 uC. Fluorescence due
to ThT binding to SOD1 mutants (presented as arbitrary units,
A.U.) for apo T54R SOD1 (N apo D90A SOD1 (N˜), apo I113T
SOD1 (¤) and apo WT SOD1 (O), during the incubation of the
samples at 37 uC. Error bars are standard deviations values
obtained from two/three repeats of the experiments.
Found at: doi:10.1371/journal.pone.0001677.s001 (0.34 MB
DOC)
Table S1 Light Scattering analysis. ThT binding fluorescence,
as well as species distribution (dimer and aggregate) and average
molecular weights of the aggregated species, as detected by light
scattering measurements, of apo I113T SOD1 after different
periods of incubation.
Found at: doi:10.1371/journal.pone.0001677.s002 (0.02 MB
DOC)
Table S2 Extraction from E. coli cells and metal reconstitution
with zinc. The metal contents of the proteins are shown as
equivalents of each metal per enzyme dimer.
Found at: doi:10.1371/journal.pone.0001677.s003 (0.02 MB
DOC)
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